Revenue at PDI falls 28%; Outsourcing improved in 2011, but not so much for manufacturing;

 @NesaNFierce: Clinical and pharma controversy in India hasn't scared off Quanticate. Article | Follow @NesaNFierce

> Outsourcing experienced a recovery in 2011, but contract manufacturing still has a way to go. More

> Revenue fell 28% at PDI, something the CSO attributes to the expiration of some contract sales deals. Article

> Amdescope, a CRO from Finland, announced that it would offer the PlexPress' TRAC (transcript analysis with the aid of affinity capture) platform for high-throughput gene expression analysis, as part of its in vitro drug interaction and preclinical ADME-Tox services. News

> Industry leaders gathered at the Avoca Group's Quality Summit this month in New Jersey, where they discussed how to ensure high-quality, outsourced clinical research. Story

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.